Predict your next investment

Venture Capital
prosperico-venture.com

See what CB Insights has to offer

Investments

26

Portfolio Exits

2

About Prosperico Venture

Prosperico Venture is a China-based VC focused on healthcare and the high-tech industry.

Prosperico Venture Headquarter Location

Room 4202, Jiahua Center 1010 Huaihai Middle Rd, Xuhui District

Shanghai, Shanghai,

China

+86 021-33566200

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Prosperico Venture News

Fourier Closes USD5 Million A-Round to Advance Rehab Robots

Feb 27, 2018

(Yicai Global) Feb. 27 — Fourier Intelligence Co., which provides physical rehabilitation via robotic exoskeletons, has secured CNY30 million (USD4.8 million) in A-round funding as it looks to further develop and commercialize its medical robots while forming a sector ecosystem. Prosperico Venture led the series with support from Shenzhen Qianhai Fund of Funds and existing investors IDG Capital and Volcanics Venture, online news outlet Lieyuan reported. Shanghai-based Fourier unveiled its first commercially available lower-body exoskeleton robot, the X1, early last year. It can be used in hospital rehabilitation programs to help paralyzed patients get out of their wheelchairs and learn to walk again. ×

Prosperico Venture Investments

26 Investments

Prosperico Venture has made 26 investments. Their latest investment was in Pharma Legacy as part of their Private Equity on October 10, 2021.

CBI Logo

Prosperico Venture Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/22/2021

Private Equity

Pharma Legacy

$100M

No

7

8/9/2021

Unattributed VC

Hengdong Biology

Yes

1

2/22/2021

Series A

Rigen Bio

Yes

3

12/30/2020

Series C

Subscribe to see more

Subscribe to see more

10

12/15/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/22/2021

8/9/2021

2/22/2021

12/30/2020

12/15/2020

Round

Private Equity

Unattributed VC

Series A

Series C

Series B

Company

Pharma Legacy

Hengdong Biology

Rigen Bio

Subscribe to see more

Subscribe to see more

Amount

$100M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

1

3

10

10

Prosperico Venture Portfolio Exits

2 Portfolio Exits

Prosperico Venture has 2 portfolio exits. Their latest portfolio exit was Chao Ju Ophthalmology on July 07, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/7/2021

IPO

2

5/15/2019

Reverse Merger

Subscribe to see more

Subscribe to see more

10

Date

7/7/2021

5/15/2019

Exit

IPO

Reverse Merger

Companies

Subscribe to see more

Valuation

Acquirer

Subscribe to see more

Sources

2

10

Prosperico Venture Team

1 Team Member

Prosperico Venture has 1 team member, including current Managing Partner, Tingzhi Qian.

Name

Work History

Title

Status

Tingzhi Qian

Managing Partner

Current

Name

Tingzhi Qian

Work History

Title

Managing Partner

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.